Our Team at CPHI India 2024

Deepak Sapra
CEO, Pharmaceutical Services & Active Ingredients

Azhar Khan
Vice President & Head, API - Emerging Markets

Siddhartha Deshpande
Associate Vice President, API Sales & Marketing, SEAMEA

Vishal N Bhojak
Director, API Sales & Marketing - SSEA

Susmit Dey
Director, API Sales & Marketing - SSEA

Netraja Jitendra Patil
Associate Director, API Sales & Marketing - Turkey, Jordan & Africa

Ashwinikumar Kulkarni
Vice President & Global Head - Demand Planning, Customer Support & Program Management
About Dr.Reddy’s API Business
We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 150+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.
Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.
-
250+ APIs
-
8 Manufacturing sites
-
1900 drug master files across global markets.
-
Over 170 ANDAs and 500 DMFs
-
More than 1000 patents field, and more than 70 own patents granted
-
Experience with complex APIs and formulations supporting early market entries.
-
Preferred pharma API supplier for pharma companies in more than 80 countries.
Sustainability is deeply embedded in our purpose and forms the core of our organization.
Our journey began with APIs in 1984, and we evolved from small molecules to large molecules and from APIs to finished formulations over the decades. Amidst this evolution, what has remained constant at the heart of our organization is a deep commitment to patients and the customers we serve through our core principles of collaboration and sustainability.
By the end of FY2024, we had served over 700 million patients and continue our endeavours to reach over 1.5 billion patients globally by 2030. This means almost one in every five people on this planet will use Dr. Reddy’s product or service. The health of people is strongly linked to the health of our planet. That's why our integrated report also shows how sustainability and business are strongly linked.
What we achieved in the past year:
Our Achievement (awards)

25/04/2024
USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”


05/04/2024
Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya


05/12/2023
Dr. Reddy's Pioneers Pharma Advancements Through Strategic Partnerships and Innovation: A Glimpse into Vision 2030: Growth Trajectory and Opportunities for Indian Pharma


04/11/2022
Dr. Reddy’s API received the excellence in API – Technical Documentation award at Aché Laboratórios Parcerias para a Excelência (Partnerships – Excellence) event!


03/11/2021
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2021


03/11/2021
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2021


11/11/2021
The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards


19/10/2020
Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’

Our Plants

About CPHI India 2024
CPHI India is the leading pharmaceutical event in the region, uniting suppliers, buyers, and industry professionals across the entire pharmaceutical supply chain. This annual gathering takes place in New Delhi, offering an unparalleled platform for the Indian pharma community to connect, collaborate, and innovate.

Key Highlights of CPHI India 2024:
-
Extensive Networking Opportunities: Engage with thousands of pharma professionals from India and around the world, fostering connections that can lead to fruitful collaborations.
-
Diverse Exhibitor Showcase: Explore a comprehensive list of exhibitors spanning every sector of the pharmaceutical market, providing insights into the latest products and services.
-
Educational Insights: Participate in conferences and discussions led by industry leaders, gaining valuable knowledge and perspectives on emerging trends and challenges.
-
Cost-Effective Solutions: Discover innovative advancements and solutions tailored to optimize your business operations and enhance efficiency.
CPHI India 2024 serves as the perfect venue to expand your business network, uncover new technologies, and forge reliable partnerships. Join us in shaping the future of the pharmaceutical industry.
Aviso Legal
Nenhuma informação neste catálogo - incluindo qualquer referência a qualquer produto ou serviço - constitui uma oferta de venda ou deve ser interpretada como uma oferta de venda. Os produtos protegidos por patentes válidas não são oferecidos ou fornecidos para uso comercial. No entanto, as quantidades de pesquisa de tais produtos podem ser oferecidas para fins de submissão regulatória, onde quer que existam tais isenções regulatórias. Os compradores devem fazer sua avaliação independente do cenário de patentes para seus respectivos mercados e serão responsáveis por todas as responsabilidades relacionadas à patente. Os produtos protegidos por patentes válidas na Índia não estão disponíveis para uso comercial, mas estariam disponíveis para os propósitos da Seção 107A.